We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Urges Transition to Abuse-Deterrent Opioid Formulations
Gottlieb Urges Transition to Abuse-Deterrent Opioid Formulations
The FDA strongly supports transitioning the opioid painkiller market toward abuse-deterrent formulations, Commissioner Scott Gottlieb told a Senate committee examining the abuse epidemic.